bpc 157 vs tb500 BPC-157/TB-500 Capsules The Peptide Therapy Protocols Bible:
Description
(2018) PCO-02 - Safety and pharmacokinetics trial - Full Text View - ClinicalTrials.gov
The rationale behind utilizing phage therapy is multi-faceted
BPC157 drives angiogenesis through FBXO22-dependent stabilization of BACH1
Health conditions like HIV, diabetes, and alcohol use disorder (alcoholism) put you at risk for vitamin B12 deficiency
The mass stays fixed at 10 mg
In less deficient areas, repeat dose every 5-6 months or as found necessary
